The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases
Autoimmune diseases (AIDs) are a group of disorders in which the immune system attacks the body’s own tissues, leading to chronic inflammation and organ damage. These diseases are difficult to treat due to variability in drug PK among individuals, patient responses to treatment, and the side effects...
Saved in:
| Main Authors: | Artur Świerczek, Dominika Batko, Elżbieta Wyska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/12/1559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are plasma drug concentrations still necessary? Rethinking the pharmacokinetic link in dose–response relationships
by: Nicolas Simon, et al.
Published: (2025-07-01) -
Population Pharmacokinetic and Exposure–Response Analyses for Ponatinib in the Phase 3 PhALLCON Study
by: Michael J. Hanley, et al.
Published: (2025-03-01) -
Precision Dosing in Presence of Multiobjective Therapies by Integrating Reinforcement Learning and PK‐PD Models: Application to Givinostat Treatment of Polycythemia Vera
by: Alessandro De Carlo, et al.
Published: (2025-06-01) -
Disease Progression Modeling of Estimated Glomerular Filtration Rate (eGFR): A Pharmacometrics Approach
by: Sohail Aziz, et al.
Published: (2025-06-01) -
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach
by: Ahsan Rizwan, et al.
Published: (2025-05-01)